MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Characterization and quantitative analysis of prelemniscal radiations in Parkinson´s disease

    M.G. Garcia-Gomar, I. Vaca-Palomares, M. Esqueda, J. Soto, J.D. Tournier, L. Concha, F. Velasco (Queretaro, Mexico)

    Objective: To characterize the connectivity of prelemniscal radiations (Raprl) and to identify differences in the fiber populations within the Raprl. Background: The Raprl have been…
  • 2016 International Congress

    Transcranial static magnetic field stimulation (tSMS) decreases motor cortex excitability in Parkinson’s disease OFF but not ON medication

    M. Dileone, M. Carrasco-López, J. Segundo-Rodriguez, L. Mordillo-Mateos, N. López-Aristegui, F. Alonso-Frech, M. Catalan-Alonso, J. Obeso, A. Oliviero, G. Foffani (Madrid, Spain)

    Objective: To test the ability of transcranial static magnetic field stimulation (tSMS) to decrease motor cortex excitability in patients with Parkinson's disease OFF vs, ON…
  • 2016 International Congress

    The effect of dopaminergic therapy on stimulus-response learning and decision-making in Parkinson’s disease using fMRI

    P.A. MacDonald, N.M. Hiebert, K.N. Seergobin, A.M. Owen (London, ON, Canada)

    Objective: Our aim was to examine the neural correlates of stimulus-response (SR) learning in patients with Parkinson's disease (PD) on and off dopaminergic (DA) therapy…
  • 2016 International Congress

    Olfactory performance and resting state functional connectivity in non-demented drug naïve patients with Parkinson’s disease

    M. Sunwoo, J.H. Ham, J.Y. Hong, Y.H. Sohn, P.H. Lee (Seongnam, Korea)

    Objective: We investigated the pattern of resting state functional connectivity in patients with PD according to olfactory performance to elucidate olfactory-dependent cortical-subcortical functional networks. Background:…
  • 2016 International Congress

    Frontal cortex grey matter integrity determines motor improvement after STN-DBS in patients with Parkinson’s disease

    M. Muthuraman, G. Deuschl, C. Riedel, J. Volkmann, S. Groppa (Mainz, Germany)

    Objective: We hypothesize that the integrity of the cortical structures is an independent predictor for the DBS response. Background: Deep brain stimulation of subthalamic nucleus…
  • 2016 International Congress

    The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson’s disease

    B.A. Pickut, W. Van Hecke, P. Cras, E. Kerckhofs, S. Vanneste, D. Crosiers, P. Marien, P.M. Parizel (Grand Rapids, MI, USA)

    Objective: The aim of the current study is to investigate the effect of an eight-week mindfulness training intervention on emotion related brain activation in people…
  • 2016 International Congress

    Evaluating quantitative EEG (QEEG) measures to differentiate between Parkinson’s disease (PD) patients and healthy individuals

    M. Chaturvedi, F. Hatz, U. Gschwandtner, V. Roth, P. Fuhr (Basel, Switzerland)

    Objective: To evaluate QEEG measures for classification of Parkinson's disease(PD) patients and healthy individuals, and eventually develop a pre-clinical composite biomarker to identify patients with…
  • 2016 International Congress

    The position of the conus medullaris and the prevalence of isolated lipoma of filum terminale in Parkinson’s disease

    H. Mori, K. Shindo (Kurashiki, Japan)

    Objective: To evaluate the positions of the conus medullaris in patients with Parkinson's disease(PD). To know the prevalence of isolated lipoma of filum terminale(LFT) in…
  • 2016 International Congress

    Novel PET Tracers of alpha-synuclein for the diagnosis of Parkinson’s disease

    E. Tsika, A. Davranche, J. Molette, E. Gabellieri, S. Papin, S. Nampally, H. Kroth, D. Lowe, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

    Objective: The aim of our project is to develop small molecular weight compounds (Morphomers™) which bind selectively to alpha-synuclein (aSyn) aggregates, in order to generate…
  • 2016 International Congress

    Magnetic resonance imaging of nigrosome-1 in the diagnosis of early Parkinson’s: Initial results of the Parkinson’s magnetic imaging repository (PaMIR)

    S.T. Schwarz, Y. Xing, A. Martin Bastida, C. Lakmali Sugathapala, M. Silverdale, J. Mclean, R. Jampana, N. Bajaj, D. Burn, P. Piccini, D. Grosset, D.P. Auer (Nottingham, United Kingdom)

    Objective: To evaluate the accuracy of T2* weighted high resolution 3T Magnetic Resonance Imaging (MRI) in the diagnosis of Parkinson's disease (PD) in a prospective…
  • « Previous Page
  • 1
  • …
  • 1471
  • 1472
  • 1473
  • 1474
  • 1475
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley